Literature DB >> 12949289

Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis.

Michelle L Peterson1, David R Jacobs, Carlos E Milla.   

Abstract

OBJECTIVE: Nutritional status is associated with pulmonary health and survival in children with cystic fibrosis (CF). This study evaluated the weight gain pattern of children with CF in relation to the longitudinal trends of their pulmonary function. Our hypothesis was that children who experience continuous weight gain at a given rate will have better average forced expiratory volume in 1 second (FEV(1)) and change in FEV(1) than children who have weight gain patterns that deviate from this rate, even when total weight gain seems adequate.
METHODS: Prospectively collected data were examined in 319 children, aged 6 to 8, who were routinely followed at the Minnesota Cystic Fibrosis Center. One to 67 measurements of weight (kg), height (cm), and FEV(1) (mL) were taken per child during this 2-year period. The data were analyzed by repeated measure regression analysis and by growth pattern analysis.
RESULTS: At baseline, a 1-kg higher initial weight was associated with a 55-mL higher average FEV(1). During the follow-up period, a 1-kg gain in weight was associated with an increase in FEV(1) by 32 mL. Children who had a steady weight gain tended to experience greater increases in FEV(1) than children who experienced periodic losses in weight.
CONCLUSIONS: We established that children who weigh more and who gain weight at an appropriate and uninterrupted rate have a better FEV(1) trajectory. Aggressive nutritional support to maintain growth in these children may therefore improve FEV(1), which can be taken as a surrogate for better lung health, and may ultimately lead to better survival.

Entities:  

Mesh:

Year:  2003        PMID: 12949289     DOI: 10.1542/peds.112.3.588

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  37 in total

1.  Nutritional supplements in cystic fibrosis.

Authors:  Matthias Kappler; Matthias Griese
Journal:  BMJ       Date:  2006-03-18

2.  The Cystic Fibrosis Symptom Progression Survey (CF-SPS) in Arabic: A Tool for Monitoring Patient's Symptoms.

Authors:  Catherine Norrish; Mark Norrish; Uwe Fass; Majid Al-Salmani; Ganji Shiva Lingam; Fiona Clark; Hebal Kallesh
Journal:  Oman Med J       Date:  2015-01

3.  Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.

Authors:  Maria R Mascarenhas; John Mondick; Jeffrey S Barrett; Martha Wilson; Virginia A Stallings; Joan I Schall
Journal:  J Clin Pharmacol       Date:  2015-03-23       Impact factor: 3.126

4.  The effects of an intensive behavior and nutrition intervention compared to standard of care on weight outcomes in CF.

Authors:  Lori J Stark; Lisa Opipari-Arrigan; Alexandra L Quittner; Judy Bean; Scott W Powers
Journal:  Pediatr Pulmonol       Date:  2010-09-01

5.  Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis.

Authors:  Don B Sanders; Zhumin Zhang; Philip M Farrell; HuiChuan J Lai
Journal:  J Cyst Fibros       Date:  2018-02-01       Impact factor: 5.482

6.  Growth trajectories and oxygen use in neuroendocrine cell hyperplasia of infancy.

Authors:  Rebekah J Nevel; Errine T Garnett; Deneen A Schaudies; Lisa R Young
Journal:  Pediatr Pulmonol       Date:  2018-02-02

7.  Mealtime problems predict outcome in clinical trial to improve nutrition in children with CF.

Authors:  Lisa Opipari-Arrigan; Scott W Powers; Alexandra L Quittner; Lori J Stark
Journal:  Pediatr Pulmonol       Date:  2010-01

8.  Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis.

Authors:  Todd Varness; Erin E Seffrood; Ellen L Connor; Michael J Rock; David B Allen
Journal:  Int J Pediatr Endocrinol       Date:  2010-01-24

9.  Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.

Authors:  Jane C Davies; Claire E Wainwright; Gerard J Canny; Mark A Chilvers; Michelle S Howenstine; Anne Munck; Jochen G Mainz; Sally Rodriguez; Haihong Li; Karl Yen; Claudia L Ordoñez; Richard Ahrens
Journal:  Am J Respir Crit Care Med       Date:  2013-06-01       Impact factor: 21.405

10.  Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening.

Authors:  Aimee C Walsh; Gilles Rault; Zhanhai Li; Virginie Scotet; Ingrid Duguépéroux; Claude Férec; Michel Roussey; Anita Laxova; Philip M Farrell
Journal:  J Cyst Fibros       Date:  2009-11-18       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.